Clinical trial Recruiting at 7 sites Observational Ages 18 and up Women only

Factors linked to breast cancer risk and outcomes

Official title: Genomic and Non-Genomic Factors Associated With Breast Cancer Risk Factors and Outcomes

Run by Memorial Sloan Kettering Cancer Center · NCT07294703 · Data updated 2026-11-12

This project will collect blood, tissue, and survey information from women with suspicious breast findings or new breast cancer seen at MSK to see which factors are linked to risk and outcomes.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment750 (estimated)
SponsorMemorial Sloan Kettering Cancer Center
Academic / other
Locations7 sites (Basking Ridge, New Jersey and 6 other locations)
StatusRecruiting
StartedDecember 8, 2025
Main results expectedDecember 8, 2031
Study endsDecember 8, 2031
Registry record updatedOctober 22, 2026
Trial IDNCT07294703 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older who present to MSK breast radiology for biopsy of a suspicious finding or who are new breast cancer patients and surgical candidates at MSK are ideal participants.

Probably not a fit

Patients with tumors smaller than 1 cm, with only microinvasion, under 18 years old, or unable to complete the survey are not likely to benefit from or be eligible for this project, and the study does not provide cancer treatment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational cohort of women presenting to Memorial Sloan Kettering sites with a suspicious breast finding undergoing biopsy or with a new breast cancer who are surgical candidates. Participants provide blood and tissue samples as well as complete questionnaires during their routine care, and data are followed through medical records. No investigational treatments are given; participation involves only specimen collection and surveys tied to standard clinical visits. The goal is to correlate demographic, clinical, and biologic features with cancer risks and outcomes over time.

Why it matters

Potential benefit: If successful, the findings could help identify factors that predict prognosis or guide more personalized care for future patients.

How similar studies have gone: Large observational cohorts and biobanks in breast cancer have previously identified important risk and outcome associations, so this approach is well established and often productive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Women 18 years and older who are patients with a suspicious breast finding who present to breast radiology at MSK for biopsy or any new breast cancer patient seen at MSK undergoing surgery.

Inclusion Criteria:

A patient cannot be considered eligible for this study unless the following conditions are met.

* Patients with a suspicious breast finding who present to breast radiology at MSK for biopsy or any new breast cancer patient who is a surgical candidate seen at MSK.
* Women 18 years of age and older are eligible to participate in the study.

Exclusion Criteria:

* Patients presenting with a suspicious breast mass or breast cancer less than 1 cm.
* Patients presenting to clinic with only microinvasion
* Patients who are less than 18 years of age
* Patients unable to complete the survey, including IDMC patients.

Where it's running

  • Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities)
    Basking Ridge, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Monmouth (All Protocol Activities)
    Middletown, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities)
    Montvale, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)
    Commack, New York, United States
    Recruiting
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities)
    Harrison, New York, United States
    Recruiting
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites)
    New York, New York, United States
    Recruiting
Show 1 more location
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites)
    Rockville Centre, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Neha Goel, MD, MPH — Memorial Sloan Kettering Cancer Center
  • Study coordinator: Neha Goel, MD, MPH
  • Email: goeln1@mskcc.org
  • Phone: 646-888-4298

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.